XML 29 R17.htm IDEA: XBRL DOCUMENT
v3.25.2

OTHER ASSETS | 6 Months Ended
--- | ---
Jun. 30, 2025
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] |
OTHER ASSETS | NOTE 9—OTHER ASSETS The following is a summary of our Other assets (dollars in thousands):
| As of June 30, 2025 |  | As of December 31, 2024
Straight-line rent receivables | $ | 219,331 |  |  | $ | 202,675 |
Deferred lease costs, net | 152,846 |  |  | 145,973 |
Accounts receivable, net (1) | 72,400 |  |  | 108,138 |
Investment in unconsolidated operating entities | 99,827 |  |  | 95,623 |
Prepaid assets | 58,303 |  |  | 71,786 |
Non-mortgage loans receivable, net | 20,915 |  |  | 28,129 |
Other intangibles, net | 11,156 |  |  | 11,513 |
Other (2) | 99,124 |  |  | 128,826 |
Total Other assets | $ | 733,902 |  |  | $ | 792,663 |
_____________________________ (1) Allowance for doubtful accounts as of June 30, 2025 and December 31, 2024 were $70.2 million and $70.3 million, respectively. (2) The balance as of June 30, 2025 includes stock warrants exercisable at any time prior to September 13, 2034 for 9.9% of the common equity of a parent company of Kindred Healthcare, LLC (together with its subsidiaries, “Kindred”) at the pre-transaction value of such common equity (the “Scion Warrants”). The balance as of December 31, 2024 includes the Scion warrants as well as stock warrants exercisable at any time prior to December 31, 2025, in whole or in part, for 11.1 million shares of Brookdale Senior Living, Inc. common stock (“Brookdale Common Stock”) at an exercise price of $3.00 per share (the “Brookdale Warrants”). During the six months ended June 30, 2025, we exercised all remaining 11.1 million Brookdale Warrants on a cashless basis (net of the $3.00 exercise price), resulting in Ventas receiving 5.7 million net shares of Brookdale Common Stock, which we sold for net cash proceeds of approximately $35.6 million (recorded within operating cash flows in our Consolidated Statements of Cash Flows). The Brookdale Warrants and the Scion Warrants are measured at fair value with changes in fair value being recognized within Other expense in our Consolidated Statements of Income.

X
- References No definition available. + Details
Name: | us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets. + References No definition available. + Details
Name: | us-gaap_OtherAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration